Abortion, changed paternity, and risk of preeclampsia in nulliparous women.

Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ (2009) 2.14

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ (2011) 1.88

Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women. Am J Epidemiol (2015) 1.76

Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64

The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia. Reprod Biol Endocrinol (2004) 1.22

Gestational hypertension in pregnancies supported by infertility treatments: role of infertility, treatments, and multiple gestations. Fertil Steril (2007) 0.96

Previous abortions and risk of pre-eclampsia. Int J Epidemiol (2008) 0.90

Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa. J Reprod Immunol (2013) 0.87

The paternal role in pre-eclampsia and giving birth to a small for gestational age infant; a population-based cohort study. BMJ Open (2012) 0.84

Genetic aspects of preeclampsia and the HELLP syndrome. J Pregnancy (2014) 0.81

Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes. Physiol Rep (2015) 0.81

Immune Mechanisms Linking Obesity and Preeclampsia. Biomolecules (2015) 0.81

Increased planned delivery contributes to declining rates of pregnancy hypertension in Australia: a population-based record linkage study. BMJ Open (2015) 0.75

Re: "Abortion,changed paternity, and risk of preeclampsia in nulliparous women". Am J Epidemiol (2003) 0.75

Risk of recurrent preterm birth among women according to change in partner. J Perinat Med (2016) 0.75

The effect of short duration sperm exposure on development of preeclampsia in primigravid women. Iran Red Crescent Med J (2012) 0.75

Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06

Timing of elective repeat cesarean delivery at term and neonatal outcomes. N Engl J Med (2009) 6.86

Association between swimming lessons and drowning in childhood: a case-control study. Arch Pediatr Adolesc Med (2009) 3.68

Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients. JAMA (2008) 3.53

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39

Childhood cancer following neonatal oxygen supplementation. J Pediatr (2005) 3.39

Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc (2005) 3.23

Decision-to-incision times and maternal and infant outcomes. Obstet Gynecol (2006) 3.15

Frequency of uterine contractions and the risk of spontaneous preterm delivery. N Engl J Med (2002) 2.78

Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension (2007) 2.77

Urinary placental growth factor and risk of preeclampsia. JAMA (2005) 2.76

Pathogenesis of preeclampsia. Annu Rev Pathol (2010) 2.66

Fetal injury associated with cesarean delivery. Obstet Gynecol (2006) 2.61

Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation (2011) 2.55

Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55

Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension (2009) 2.51

Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol (2008) 2.21

Development of a nomogram for prediction of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 2.19

Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol (2006) 2.15

First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab (2004) 2.11

Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol (2006) 2.07

Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis (2010) 2.02

Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation (2012) 1.88

Endoscopic evaluation of patients with dyspepsia: results from the national endoscopic data repository. Gastroenterology (2004) 1.88

Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res (2007) 1.78

In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-age children. Am J Epidemiol (2005) 1.75

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol (2002) 1.70

Prediction of uterine rupture associated with attempted vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.70

Delayed postpartum preeclampsia: an experience of 151 cases. Am J Obstet Gynecol (2004) 1.69

The National Children's Study of environmental effects on child health and development. Environ Health Perspect (2003) 1.68

Dietary intake of selected nutrients affects bacterial vaginosis in women. J Nutr (2007) 1.68

Prediction and prevention of recurrent preeclampsia. Obstet Gynecol (2008) 1.66

Risk of uterine rupture with a trial of labor in women with multiple and single prior cesarean delivery. Obstet Gynecol (2006) 1.65

A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol (2008) 1.63

Prenatal exposure to 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene (p,p'-DDE) in relation to child growth. Int J Epidemiol (2006) 1.62

The association between intrauterine growth restriction in the full-term infant and high blood pressure at age 7 years: results from the Collaborative Perinatal Project. Int J Epidemiol (2006) 1.60

Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology (2007) 1.58

Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States. Clin Gastroenterol Hepatol (2005) 1.55

Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes. Obstet Gynecol (2011) 1.54

The MFMU Cesarean Registry: factors affecting the success of trial of labor after previous cesarean delivery. Am J Obstet Gynecol (2005) 1.54

Relationship of maternal body mass index and height to twinning. Obstet Gynecol (2005) 1.53

Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol (2007) 1.52

Maternal smoking during pregnancy in relation to child overweight: follow-up to age 8 years. Int J Epidemiol (2005) 1.51

Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet Gynecol (2009) 1.49

Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol (2003) 1.48

An unexpected distribution of sodium concentration in serum specimens stored for more than 30 years. Ann Epidemiol (2003) 1.48

Racial disparities in the association between birth weight in the term infant and blood pressure at age 7 years: results from the collaborative perinatal project. J Am Soc Nephrol (2006) 1.48

Risk of uterine rupture and adverse perinatal outcome at term after cesarean delivery. Obstet Gynecol (2007) 1.42

Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet (2003) 1.42

Maternal serum level of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and risk of cryptorchidism, hypospadias, and polythelia among male offspring. Am J Epidemiol (2002) 1.40

A cross-sectional analysis of the prevalence of Barrett esophagus in otolaryngology patients with laryngeal symptoms. J Clin Gastroenterol (2013) 1.40

Comparison of transverse and vertical skin incision for emergency cesarean delivery. Obstet Gynecol (2010) 1.39

The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol (2008) 1.37

Outcomes of induction of labor after one prior cesarean. Obstet Gynecol (2007) 1.34

Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol (2002) 1.33

Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet Gynecol (2010) 1.31

Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr (2008) 1.30

Postpartum headache: is your work-up complete? Am J Obstet Gynecol (2007) 1.27

Failed operative vaginal delivery. Obstet Gynecol (2009) 1.27

Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol (2005) 1.26

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One (2010) 1.25

Is a change in the vaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol (2005) 1.24

Comparison of maternal and infant outcomes from primary cesarean delivery during the second compared with first stage of labor. Obstet Gynecol (2007) 1.24

Maternal serum levels of polychlorinated biphenyls and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and time to pregnancy. Am J Epidemiol (2005) 1.23

The association of psychosocial stress and bacterial vaginosis in a longitudinal cohort. Am J Obstet Gynecol (2006) 1.22

Prenatal exposure to low-level polychlorinated biphenyls in relation to mental and motor development at 8 months. Am J Epidemiol (2003) 1.20

Circulating chemokine levels and miscarriage. Am J Epidemiol (2007) 1.19

Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol (2003) 1.17

Evaluation and management of severe preeclampsia before 34 weeks' gestation. Am J Obstet Gynecol (2011) 1.16

Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol (2005) 1.16

Maternal vitamin D status and spontaneous preterm birth by placental histology in the US Collaborative Perinatal Project. Am J Epidemiol (2013) 1.15

Circulating angiogenic factors and placental abruption. Obstet Gynecol (2006) 1.15

Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol (2002) 1.15

Maternal serum 25-hydroxyvitamin D and measures of newborn and placental weight in a U.S. multicenter cohort study. J Clin Endocrinol Metab (2012) 1.14

Prenatal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect (2004) 1.14

Sperm chromatin structure assay as an independent predictor of fertility in vivo: a case-control study. Int J Androl (2009) 1.14

Birth weight, postnatal growth, and risk for high blood pressure at 7 years of age: results from the Collaborative Perinatal Project. Pediatrics (2007) 1.13

Perioperative morbidity and mortality among human immunodeficiency virus infected women undergoing cesarean delivery. Obstet Gynecol (2007) 1.13

Maternal levels of polychlorinated biphenyls in relation to preterm and small-for-gestational-age birth. Epidemiology (2005) 1.13

Reliability of maternal recall and reporting of child births and deaths in rural Egypt. Paediatr Perinat Epidemiol (2003) 1.13

Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth. Am J Epidemiol (2008) 1.13

Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol (2004) 1.11

Indications for delivery and short-term neonatal outcomes in late preterm as compared with term births. Am J Obstet Gynecol (2009) 1.09

The MFMU Cesarean Registry: impact of time of day on cesarean complications. Am J Obstet Gynecol (2006) 1.09

Antioxidant supplementation and premature rupture of the membranes: a planned secondary analysis. Am J Obstet Gynecol (2008) 1.08

Blood transfusion and cesarean delivery. Obstet Gynecol (2006) 1.08

Less-tight versus tight control of hypertension in pregnancy. N Engl J Med (2015) 1.07

Maternal and neonatal outcomes of repeat cesarean delivery in women with a prior classical versus low transverse uterine incision. Am J Perinatol (2010) 1.07

Circulating levels of cytokines during pregnancy: thrombopoietin is elevated in miscarriage. Fertil Steril (2007) 1.07

Maternal serum level of the DDT metabolite DDE in relation to fetal loss in previous pregnancies. Environ Res (2005) 1.07

Preeclampsia: Diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med (2006) 1.06

Is bacterial vaginosis a stronger risk factor for preterm birth when it is diagnosed earlier in gestation? Am J Obstet Gynecol (2005) 1.06

Severe sepsis and septic shock in pregnancy. Obstet Gynecol (2012) 1.05

Maternal vitamin D status and the risk of mild and severe preeclampsia. Epidemiology (2014) 1.05

Polychlorinated biphenyls and menstrual cycle characteristics. Epidemiology (2005) 1.04

In utero exposure to polychlorinated biphenyls and sensorineural hearing loss in 8-year-old children. Neurotoxicol Teratol (2004) 1.03

The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med (2010) 1.03